Two Sigma Investments
SCPH

Two Sigma Investments’s scPharmaceuticals SCPH Stock Holding History

Two Sigma Investments’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,700
Closed -$79.6K – 3348
2023
Q4 		$79.6K Sell
12,700
-19,300
-60% -$111K ﹤0.01% 2962
2023
Q3 		$228K Sell
32,000
-19,000
-37% -$150K ﹤0.01% 2595
2023
Q2 		$520K Sell
51,000
-198,067
-80% -$2.07M ﹤0.01% 2314
2023
Q1 		$2.26M Buy
249,067
+60,112
+32% +$440K 0.01% 1307
2022
Q4 		$1.35M Buy
+188,955
New +$1.15M ﹤0.01% 1544
2020
Q4 		– Sell
-26,369
Closed -$196K – 3838
2020
Q3 		$196K Buy
+26,369
New +$206K ﹤0.01% 2828

Other funds holding SCPH

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
JGC
J. Goldman & Co New York $2.16B AUM 33.8% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return